Tofacitinib (rheumatoid arthritis) - Addendum to Commission A21-115

Report documents

1. Addendum

   Tofacitinib (rheumatoid arthritis) - Addendum to Commission A21-115

   published on

   17.02.2022

   Document type

   PDF-Dokument, 293 kB, DE, PDF

   Download file : Addendum (PDF-Dokument, 293 kB, DE, PDF)

Additional information

Project details

Project no.

G22-03

Commission

Commission awarded on 11.01.2022 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Health Economics

Topic

Immune system and infections

Note

If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.

Connected Projects

1. Dossier assessment

   Tofacitinib (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V (new scientific findings)

   Project no.

   A21-115

   Last updated

   17.02.2022

   Status: Commission completed